← Leaderboards
Madhusudan Viswanath Peshwa
Neocytex Biopharma, Inc.
$1,062,743
Attributed
$1,062,743
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $414.7K · FY2006–09$500K$375K$250K$125K$0
'06
'07
'08
'09
Funding mix
By agency
NIH$1,062,743 · 3
By mechanism
R44$809,064 · 1
R43$253,679 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Cost Effective”
- Lawrence Corey · Fred Hutchinson Cancer Center$305,188,797
- David R. Weir · University Of Michigan At Ann Arbor$265,604,440
- Jeffrey P Krischer · University Of South Florida$257,227,881
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Everette D Joseph · Howard University$243,972,016
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
Research focus
Cost EffectiveDentalClinical ResearchContractsAchievementCyclic GmpAge Related Macular DegenerationClinical ApplicationBeta ThalassemiaClinical TrialsBiological ProductsBioprocessBioreactorsBuffersAreaAgitationBaseClinicCell LineCell PhysiologyBiologicalAlphavirusCellsDependovirus
Grant awards (4)
Development of a Production Method for Scaling Up Lentiviral Vector Manufacture$394,406
R44 · FY2009 · HL · contact PI
Development of a Production Method for Scaling Up Lentiviral Vector Manufacture$414,658
R44 · FY2008 · HL · contact PI
Development of a production method for scaling up lentiviral vector manufacture$116,893
R43 · FY2006 · HL · contact PI
Enhanced Neural Stem Cell Production in the Aging Brain$136,786
R43 · FY2004 · AG